TRACY SALAZAR: Open Payments
NPI 1366844342 · MEDINA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 31 payments from 11 companies in 2025. Trend: 2023 $394 · 2024 $290 · 2025 $607
Food & beverage: $522Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $248 |
| Janssen Biotech, Inc. | 2 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $29 |
| Madrigal Pharmaceuticals | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| QOL Medical, LLC | 1 | $22 |
| Ardelyx, Inc. | 1 | $20 |
| GENZYME CORPORATION | 1 | $16 |
Products named: RINVOQ, SKYRIZI, TREMFYA, EOHILIA, IQIRVO, XIFAXAN, REZDIFFRA, ZENPEP.
Industry payments across OH — which companies pay providers there.
